Landmark breast cancer study paves way for tailored treatments
18 Apr 2012Researchers have identified 10 different types of the disease, laying groundwork for more effective, targeted treatment plans.
News from the School of Clinical Medicine at the University of Cambridge.
Researchers have identified 10 different types of the disease, laying groundwork for more effective, targeted treatment plans.
A new Regius Professor of Physic at the University of Cambridge has been approved by Her Majesty The Queen to succeed Professor Sir Patrick Sissons who will retire on 30 September 2012.
New discoveries by Cambridge scientists about a molecular waste-disposal process that ‘eats’ bacteria are influencing the clinical management of cystic fibrosis, and could be the basis of innovative new treatments to fight off bacteria.
Study suggests that anti-inflammatory drugs could be used to treat cardiovascular disease.
Patient information reveals women, young people, ethnic minorities and people with less common cancers have the highest number of pre-referral consultations.
A collaborative project between physicists, oncologists and computer scientists at Oxford and Cambridge Universities, launched last month, will develop improved tools for the planning of high precision radiotherapy. Accel-RT will also help overcome time constraints that currently limit the use of complex radiotherapy treatment.
Researchers have discovered how receptors for the female sex hormone oestrogen attach to a different part of the DNA in breast cancer patients who are more likely to relapse.
Six members of the University have been recognised in the Queen’s New Year Honours list.
A collaboration between virologists and neuroscientists at Cambridge University has demonstrated how viruses that cross the blood/brain barrier could be exploited to slow down, or even halt, the progress of Parkinson’s and other neurodegenerative diseases.
Scan can detect 5p-sized growth that causes hypertension.